It is a pharma private limited company based in New Delhi, Delhi, India, established in 2022.
2022 | New Delhi, Delhi, India | ActiveAlde Expression Lifesciences Private Limited, a active private limited company, was established on 28 April 2022 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24110DL2022PTC397543. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.60 Cr.
It upholds a compliant status. Its leadership includes Himani Singh (Director), Rahul Singh (Director), Kanishk Pratap Singh (Director). It holds ₹20.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block-A, 71/2C, First Floor,, Rama Road,, New Delhi, Delhi, 110015.
U24110DL2022PTC397543
397543
28 April 2022
₹5.00 Cr
₹4.60 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Alde Expression Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Himani Singh | Director | 03 Jul 2023 | Current |
| Rahul Singh | Director | 28 Apr 2022 | Current |
| Kanishk Pratap Singh | Director | 28 Apr 2022 | Current |
| Manas Rastogi | Director | 28 Apr 2022 | Current |
| Mehul Rastogi | Director | 28 Apr 2022 | Current |
| Ritu Kumar | Additional Director | 23 Feb 2023 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alde Expression Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 20397.74% increase. The company also saw a substantial fall in profitability, with a 565.16% decrease in profit. The company's net worth Soared by an impressive increase of 5368.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Alde Expression Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹200,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Apr 2024 | Others | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
Alde Expression Lifesciences has a workforce of 0 employees as of Oct 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alde Expression Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alde Expression Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Alde Expression Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100922583 was registered on 22 Apr 2024. was documented.
Progress on Alde Expression Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Himani Singh was appointed as a Director was appointed as a Director on 03 Jul 2023 & has been associated with this company since 2 years 5 months . was completed.
The activity Ritu Kumar was appointed as a Additional Director was appointed as a Additional Director on 23 Feb 2023 & has been associated with this company since 2 years 9 months . was completed.
The activity Rahul Singh was appointed as a Director was appointed as a Director on 28 Apr 2022 & has been associated with this company since 3 years 7 months . was completed.
The CIN of Alde Expression Lifesciences Private Limited is U24110DL2022PTC397543.
Alde Expression Lifesciences Private Limited is headquartered at Block-A, 71/2C, First Floor,, Rama Road,, New Delhi, Delhi, 110015.
Alde Expression Lifesciences Private Limited was incorporated on 28 April 2022.
The current directors of Alde Expression Lifesciences Private Limited are
The primary industry of Alde Expression Lifesciences Private Limited is Pharma.
Alde Expression Lifesciences Private Limited is unlisted.
The authorized capital of Alde Expression Lifesciences Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.60 Cr.
The compliance status of Alde Expression Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX